HEP B Vaccine Engerix-B
Engerix-B is a recombinant, single-antigen hepatitis B vaccine approved in the US for infants at birth through adulthood.
The CDC recommends that all infants receive the first dose of the hepatitis B vaccine at birth, followed by two additional doses at one and six months old.
Each infant and pediatric dose of Engerix-B contains 0.25mg of aluminum hydroxide.